About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6558 record(s)
Req # A-2024-001188
Adverse Drug Reaction (ADR). Report number: E2B_07457396.Organization: Health Canada
January 2025
Req # A-2024-001189
Adverse Drug Reactions (ADRs). Report numbers: E2B_07458564, E2B_07467813.Organization: Health Canada
January 2025
Req # A-2024-001191
Adverse Drug Reactions (ADRs). Report numbers: 001100939, 001103018, 001104642, E2B_07208128, E2B_07241676.Organization: Health Canada
January 2025
Req # A-2024-001192
Adverse Drug Reaction (ADR) for Dexilant. Report number: E2B_07470391. ADRs for Entyvio. Report numbers: E2B_07461648, E2B_07452627, 001110995, E2B_07490527. ADRs for Lisdexamfetamine dimesylate. Report numbers: E2B_07494414, E2B_07458121,…Organization: Health Canada
January 2025
Req # A-2024-001193
Adverse Drug Reactions (ADRs) for Ondansetron. Report numbers: 001119129, E2B_07504484, 001112118, E2B_07504969, E2B_07502047, 001109962, 001112788. ADRs for Immunoglobulin (human). Report numbers: E2B_07485309, E2B_07497976, E2B_07459838.Organization: Health Canada
January 2025
Req # A-2024-001196
Adverse Drug Reaction (ADR) for Amphetamine aspartate monohydrate/ amphetamine sulfate/ dextroamphetamine saccharate/ dextroamphetamine sulfate. Report number: 001110987. ADR for Mesalazine. Report number: E2B_07475683. ADRs for C1 Esterase…Organization: Health Canada
January 2025
Req # A-2024-001199
Adverse Drug Reaction (ADR). Report number: 001105120.Organization: Health Canada
January 2025
Req # A-2024-001206
Adverse Drug Reactions (ADRs). Report numbers: E2B_07490565, 001108811, 001124193, 001117067.Organization: Health Canada
January 2025
Req # A-2024-001208
Adverse Drug Reactions (ADRs). Report numbers: 001103378, 001101755, 001104894, 001104628, 001102411, 001101188, 001102208, E2B_07385877, E2B_07358095, E2B_07412651.Organization: Health Canada
January 2025
Req # A-2024-001212
Adverse Drug Reaction (ADR). Report number: E2B_07231496.Organization: Health Canada
January 2025